Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Oncology Innovations

Episode 4: Industry Standards Needed for Next-Generation Sequencing in Cancer Care

Read the Transcript

On episode 4 of Oncology Innovations, host Gordon Kuntz sits down with Ira Klein, MD, MBA, of Tempus Labs, to discuss the need for industry standards in next-generation sequencing (NGS) and comprehensive genomic profiling (CGP). Gordon and Dr Klein address how the lack of standards is hurting patients and providers in terms of access and administrative waste and is hurting payers in subverting care to wasteful therapies and curving use of clinical trials.

Catch up with more episodes of Oncology Innovations.

Advertisement

Advertisement

Advertisement